Bill
Bill > S0143
RI S0143
RI S0143Establishes a program within the adult correctional institution to permit medication assisted treatment approved by the FDA to be provided for the treatment of opioid use disorder to any incarcerated individual.
summary
Introduced
01/31/2025
01/31/2025
In Committee
01/31/2025
01/31/2025
Crossed Over
Passed
Dead
06/20/2025
06/20/2025
Introduced Session
2025 Regular Session
Bill Summary
This act would establish a program within the adult correctional institutions to permit medication for opioid use disorder approved by the FDA to be provided for the treatment of an opioid use disorder to any individual incarcerated. Each inmate would be screened for opioid use disorder within twenty-four (24) hours of incarceration and if determined to be suffering from an opioid use disorder would be offered placement in the medication for opioid use disorder program. This act would take effect on January 1, 2026.
AI Summary
This bill establishes a comprehensive medication-assisted treatment (MAT) program for individuals with opioid use disorder within adult correctional institutions. The program requires screening all inmates within 24 hours of admission for opioid use disorder and offering voluntary participation in a treatment program that includes FDA-approved medications. Key provisions include ensuring that inmates can enter the program at any time during incarceration, prohibiting discrimination against participants based on drug screenings or disciplinary history, and providing a re-entry strategy that includes connecting participants with treatment facilities, housing, and employment resources. The program mandates individualized treatment plans developed by qualified healthcare professionals, protects participants' rights to continue medication prescribed prior to incarceration, and requires the department to submit annual reports to the governor and general assembly evaluating the program's effectiveness. Importantly, the bill emphasizes that participation is voluntary, medical decisions remain with healthcare professionals, and the program must follow existing state and federal guidelines for opioid treatment. The program is set to take effect on January 1, 2026, with the goal of supporting inmates in managing opioid use disorder and facilitating successful rehabilitation and reintegration.
Committee Categories
Justice
Sponsors (7)
Meghan Kallman (D)*,
Jacob Bissaillon (D),
Alana DiMario (D),
Pam Lauria (D),
Tiara Mack (D),
Melissa Murray (D),
Bridget Valverde (D),
Last Action
Committee recommended measure be held for further study (on 04/03/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://status.rilegislature.gov/ |
BillText | https://webserver.rilegislature.gov/BillText25/SenateText25/S0143.pdf |
Loading...